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SUMMARY
Rats injected with peptidoglycan-polysaccharide polymers derived from group A streptococcal cell
walls (PG-APS) develop a chronic, remittant, erosive synovitis. Spleen cells from injected rats failed
to proliferate when stimulated in vitro by Con A or PHA, unless nylon wool adherent cells were first
removed. The suppression could also be reversed by removing phagocytic cells which had ingested
carbonyl iron. Cells from control rats were suppressed in vitro by co-culture with unfractionated or
nylon wool-adherent cells from PG-APS injected rats, and the suppressor activity was still expressed
after exposure of the suppressor cells to 3,000 rad of irradiation. Addition of catalase and
indomethacin to cultures only partially reversed the suppression. T lymphocytes from rats given a
single arthropathic dose of PG-APS remained suppressed for at least 86 days after injection. Cells
from rats given a low, non-arthropathic dose of PG-APS did not become suppressed. Cells from the
Buffalo rat, which is resistant to development of PG-APS-induced chronic arthritis, showed less
suppression than cells from the susceptible Lewis and Sprague-Dawley rat strains.
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INTRODUCTION
Decreased cell mediated immunity (CMI) can be demonstrated
in many diseases characterized by chronic inflammation, both
naturally occurring and experimentally induced. A depressed
CMI response has been reported in chronic bacterial infections
such as tuberculosis (Wadee, Mendelsohn & Rabson, 1983),
listerosis (Petit et al., 1985), and leprosy (Salgame, Mahadevan
& Antia, 1983); fungal infections such as histoplasmosis
(Nickerson, Havens & Bullock, 1981); some solid tumors (Pope
et al, 1976), and in certain chronic inflammatory diseases of
unknown etiology such as sarcoidosis (Muraguchi et al., 1982).
Depression ofnormal CMI is also observed in some patients
with rheumatoid arthritis (RA). Impaired CMI is evidenced in
vivo by decreased skin test reactivity on the part ofRA patients
to PPD and other antigens (Waxman et al., 1973; Andrianakos
et al., 1977), and in vitro by decreased proliferation of lympho-
cytes to both mitogenic and antigenic stimuli. Studies in vitro
have been performed using both synovial fluid cells (Zembala &
Lemmel, 1980; Silver et al., 1983), and peripheral blood
leucocytes (Seitz, Deimann & Gemsa, 1981; Panush, 1982) from
RA patients.
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This paper reports alterations of CMI in a rat model of
arthritis in which rats are given a single intraperitoneal injection
of an aqueous suspension of peptidoglycan-polysaccharide
polymers purified from the cell walls of group A streptococci
(PG-APS). These rats develop an acute and chronic, remittant,
erosive synovitis with clinical, histological and radiological
findings similar to those of human disease (Cromartie et al.,
1977; Clark et al., 1979; Dalldorf et al., 1980; Wilder et al.,
1983). Earlier work demonstrated that rats given an arthro-
pathic dose of PG-APS were unresponsive to skin testing with
peptidoglycan antigen (Hunter et al., 1980). The studies de-
scribed here show that depressed T lymphocyte function is
associated with an adherent cell which has the biological
properties of a macrophage.
MATERIALS AND METHODS
Peptidogtycan-potysaccharidepotymersfrom group A streptococ-
cal cell walls (PG-APS)
The method for preparing the PG-APS used to induce the joint
disease has been described (Hunter et al., 1980). Briefly, group A
strain D-58 Streptococcus pyogenes was grown in Todd-Hewitt
broth (BBL, Microbiology Systems, Cockeysville, MD) to early
stationary phase. Cells were harvested by centrifugation and
broken in a Braun MSK shaker (Bronwill Scientific Inc.,
Rochester, NY). Cell wall fragments were separated from
cellular debris by centrifugation, and the PG-APS was extracted
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with chloroform/methanol, and treated with trypsin, papain,
and RNAse. Purified PG-APS was washed five times with
phosphate-buffered saline (PBS) by centrifugation at 10,000 g
for 30 min, dialysed against distilled water and lyophilized. The
PG-APS was prepared for injection by suspension in sterile PBS
and sonication for 70 min in a Branson Sonifier (Branson Sonic
Power Co., Danbury, CT). This preparation was centrifuged at
10,000 g for 30 min and then filtered through a 0 45 pm filter
(Millipore Corp., Bedford, MA). Sterility was confirmed by
culturing 01 ml of sonicate on a blood agar plate. The
concentration of PG-APS was calculated by a calorimetric
assay for rhamnose (Dische & Shettles, 1948), and all doses are
expressed in terms of micrograms of rhamnose per gram body
weight (pg rh/gbw).
Animals
Inbred Lewis and outbred Sprague-Dawley female rats were
obtained from the Chales River Breeding Laboratories Inc.,
Wilmington, MA. Buffalo inbred female rats were obtained
from Simonson Breeding laboratories, Bilroy, CA. Rats were
allowed access to food and water ad libitm, and weighed about
120 grams when injected. Rats were injected intraperitoneally,
under ether anaesthesia, with PG-APS in an arthropathic dose
of 20 pg rh/gbw. Control rats were injected with equivalent
volumes of sterile PBS. The severity of the arthritis was scored
from 0-4 for each limb, based on the amount of swelling,
erythema, and joint deformity. The maximum possible score for
an animal is 16 (Cromartie et al., 1977).
Spleen cell preparation
Rats were killed by decapitation 7 days after PG-APS injection,
unless otherwise indicated. Rats from different treatment
groups were killed in rotation to equalize the amount of time
cells were kept on ice before further processing. Single cell
suspensions were achieved by gently grinding spleens in loose
fitting glass tissue grinders (Kontes Scientific Glassware, Vine-
land, NJ).
Cellfraction preparation
Non-adherent and adherent cells were prepared using nylon
wool. Pre-washed wool (Leukopac, Fenwal Laboratories, Deer-
field, IL) was packed into 10 ml syringe columns and auto-
claved. Columns were washed immediately before use with two
volumes ofmedia at 370C, containing 10% heat inactivated fetal
calf serum (FCS). Approximately 2-5 x 108 cells were suspended
in 5 ml ofwarm media supplemented with 10% FCS then loaded
onto the columns. In experiments using cells pooled from
several animals, cells were pooled prior to nylon wool filtration.
Cells were incubated on the columns for 1 h in a 37 C, 5% CO2,
humidity incubator. After incubation, non-adherent cells were
eluted from the columns by the slow addition of two volumes of
media at 370C, supplemented with 10% FCS. Adherent cells
were recovered by first washing the columns with one volume of
media at 370C, added quickly to remove loosely adherent cells,
then rapidly drawing up and expressing two volumes ofmedia at
40C, without FCS, using the sterile plungers removed earlier
from the syringes.
Phagocyte-depleted cells were prepared by suspending
2-5 x 108 cells in 100 ml of RPMI-1640 supplemented with 10%
FCS to which 8 mg/ml ofcarbonyl iron (45 -52 pm particle size,
Sigma Chemical Company, St. Louis, MO) had been added.
Cells were incubated for I h at 370C with gentle mixing by tube
inversion every 15 min. Phagocytic cells and excess iron were
removed by resting the tube on a magnet for 1-2 min, then
decanting the supernatant. This procedure was repeated five
times. The viability of all cell populations exceeded 98% as
determined by trypan blue exclusion.
Irradiated cells were prepared by suspending the cells in
RPMI-1640 at 1 x 106/ml, and exposing them to 3,000 rad from
a Caesium irradiator (Atomic Energy of Canada).
Cell identification
All studies were done in 96-well round-bottom tissue culture
plates. To enumerate macrophages, 25 pl of a 5% suspension of
latex beads (1 1 pm, Sigma Chemical Co., St. Louis, MO) per
2 x 107 cells was added to cell suspensions, and incubated at
37 C for 1 h with gentle mixing every 5 min. Free beads were
separated from cells by centrifugation through a discontinuous
density gradient of FCS. The percentage of cells which had
phagocytosed latex beads was determined by phase contrast
microscopy. T cells were identified by incubating in a 1:1000
dilution of the W3/13 monoclonal antibody (Pel-Freez Biologi-
cals, Rogers, AR), for 1 h with frequent mixing, followed by
incubation with a 1:200 dilution of fluorescein isothiocyanate
(FITC) labelled goat anti-mouse antiserum (Sigma Chemical
Co., St. Louis, MO) under the same conditions. The percentage
of labelled cells was determined by fluorescence microscopy. All
labelling procedures were carried out in 0 01 M PBS, pH 7-2
containing 0 1 % azide and 0-25% bovine serum albumin.
Media
Tissue culture media were prepared by supplementing 500 ml of
RPMI-1640 with 12 ml of 7 5% sodium bicarbonate, 50 ml of
heat-inactivated (560C, 30 min) FCS, 5 ml of 1 M hepes buffer, 5
ml of 200 mm glutamine, gentamicin to a final concentration of
0-1 mg/ml, and 5 ml of 5 x 10-3 M 2-mercaptoethanol. The
medium used for cell preparative procedures was RPMI-1640
supplemented with 10% FCS.
Cell Culture
The T cell mitogens Con A (Pharmacia Fine Chemicals,
Piscataway, NJ) and PHA-p (Difco Laboratories, Detroit, MI)
were prepared immediately before use by dissolving in RPMI-
1640 followed by filtration through a 0 20 pm membrane filter.
Catalase (Sigma Chemical Co., St. Louis, MO) was diluted in
0- 1 M phosphate-buffered saline, dialysed to remove thymol, and
filter sterilized. Catalase was used in cultures at a final
concentration of 10,000 units/ml. Indomethacin (Sigma Chemi-
cal Co., St. Louis, MO) was used in culture at a final
concentration of I x 10-6 M, and was prepared by dissolving in
20 p1 of ethanol, then diluting in RPMI- 1640 followed by filter
sterilization. Cells were cultured in a total volume of 220 p1 of
media at 1 x 106 cells/ml in 96-well flat-bottomed tissue culture
plates (Falcon, Cockeysville, MD). Mitogen cultures were
incubated for 72 h at 370C, in a 5% CO2, 100% humidity
incubator. Proliferating cells were labelled by the addition of0 5
pCi of 3H-thymidine (Moravek Biochemicals, Brea, CA) 8 h
before harvest. Cells were harvested and washed using a MASH
II apparatus (Microbiological Associates, Walkersville, MD),
and the amount of incorporated 3H-thymidine determined in a
Beckmann 7500 series scintillation counter (Beckmann Instru-
ments, Fullerton, CA).
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RESULTS
Suppression of T Lymphocyte response to mitogens by adherent,
phagocytic, radiation-resistant cells
Spleen cells from Lewis rats injected with an arthropathic dose
of PG-APS (20 pg rhamnose/g bw) did not proliferate when
stimulated by Con A over a range of mitogen concentrations
which maximally stimulate cells from control rats (Fig 1).
Removal of nylon wool-adherent cells restored the proliferative
response of spleen cells from PG-APS injected animals, and the
remaining non-adherent cells demonstrated normal mitogen
dose-response kinetics (Fig. 1). Similar results were obtained
when cells were stimulated with PHA in a range of mitogen
concentrations from 5 to 800 pg per well.
The response to PHA and Con A of spleen cells from rats
given a non-arthropathic dose of PG-APS (2 0 pg rhamnose/g
bw) was not different from control cells at either day 7 or day 21
after injection (data not shown).
To determine the T lymphocyte and macrophage composi-
tion of the different cell preparations, T lymphocytes were
stained with the W3/13 pan-T cell monoclonal antibody, and
macrophages were identified by the phagocytosis of latex beads.
Spleen cells were derived from contol rats injected with buffered
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Fig. 1. Effect of an arthropathic dose of PG-APS (20 pg rh/gbw) on the
proliferative response of spleen cells stimulated by Con A. Each point is
the mean ct/min of quadruplicate cultures of cells pooled from five
animals in each group. Cells were harvested 7 days after injection ofPG-
APS. U, unfractionated cells from PG-APS injected rats; 0 non-
adherent cells from PG-APS injected rats; 0, unfractionated cells from
control rats; 0, non-adherent cells from control rats.





Fig. 2. Suppression ofnormal spleen cell proliferation by co-culture with
spleen cells from PG-APS injected rats. Cuf, control unfractionated
cells; Euf, unfractionated spleen cells from rats injected 7 days
previously with PG-APS; Ca, control adherent cells; Ea, adherent cells
from PG-APS injected rats. Each value is the mean of two experiments
in which cells were pooled from five control Lewis rats of five Lewis rats
injected with PG-APS.
Table 1. Elimination of suppressor activity by removing spleen cells
which phagocytose carbonyl iron
Mitogen
Cells Con A PHA
Control unfractionated 214,496+ 15,510 94,069+ 3,908
Control non-adherent 100,145+ 13,852 81,537 +6,654
Control phagocyte depleted 170,201 + 13,952 100,951 + 8,131
PG-APS unfractionated 15,461 +3,312 5,963 + 1,445
PG-APS non-adherent 165,319 + 10,552 77,395 + 7,912
PG-APS phagocyte depleted 173,601 + 6,332 73,793 + 6,181
Results are expressed as mean + 1 standard deviation ofct/min from
quadruplicate cultures of cells pooled from five control animals or five
rats injected with PG-APS. Cultures were stimulated with 1 0 pg ofCon
A or 25 ug of PHA per well.
percentages of T cells and macrophages in each cell fraction
were similar for cells taken from control and PG-APS injected
rats. Nylon wool filtration, by removing both macrophages and
B lymphocytes, increased the percentage of T cells from about
25% to 75%, and decreased the percentage of macrophages
from about 17% to 4%. Removing actively phagocytic cells with
carbonyl iron also reduced the percentage of macrophages to
about 4%. Adherent cells recovered from the nylon wool
columns were about 16% T lymphocytes and 45% macro-
phages.
Adherent cells recovered from the nylon wool columns have
suppressor activity, as shown by co-culture with control spleen
cells (Fig. 2). Both unfractionated and adherent spleen cells
from PG-APS injected rats significantly (P<0 01) suppressed
control cell responses to PHA or Con A.
Removal of cells which phagocytose carbonyl iron restored
proliferative capacity to spleen cells from PG-APS injected rats
(Table 1).
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Table 2. Effect of addition of catalase and indomethacin to in vitro cultures
Catalase +
Cells Control Catalase Indomethacin Indomethacin
Control unfractionated 108,352+ 5,419 111,767+ 6,676 111,375+9,482 110,096+13,053
PG-APS unfractionated 6,793+3,717 10,630+ 3,524 5,770+ 1,556 15,466+ 7,134
Co-culture control +PG-APS cells 14,498 +8,952 37,792+11,545 30,171+8,095 69,362+15,128
Results are the mean ct/min + 1 s.d. of quadruplicate cultures of cells pooled from five control rats or five
rats injected with PG-APS. Cultures were stimulated with 1 0 Yg Con A per well.
Table 3. Persistence of PG-APS induced suppression
Day after Percent of Control PG-APS Percent
PG-APS Control Un- PG-APS Un- control non- non- of control
injection fractionated fractionated response adherent adherent response
7 166,639 9,047 5 127,927 124,092 97
21 158,199 7,399 5 115,222 75,537 68
32 131,775 3,119 2 99,833 76,387 76
34 82,515 2,764 3 54,693 38,854 71
86 76,552 1,837 2 28,093 1,886 7
370 94,404 141,099 142 120,410 62,874 55
Results are mean ct/min of quadruplicate cultures of spleen cells pooled from five
rats killed at each interval after PG-APS injection and stimulated with Con A (1 0Mg
per well). Control rats were injected with buffered saline.
Table 4. Comparison of suppression of T cell response in three rat strains
Control un- PG-APS un- Control non- PG-APS
Strain fractionated fractionated adherent non-adherent
Lewis 146,613 +21,836 7,686+ 1,781 102,123 + 12,939 126,081 + 10,799
Buffalo 123,094+24,836 87,699+ 6,578 139,549 + 29,264 115,117 + 5,968
Sprague-Dawley 120,512 + 22,358 9,111 +6,277 112,892+22,018 97,221+ 54,156
Results are mean ct/min + I s.d. of quadruplicate cultures of pooled spleen cells from
five control rats or five rats injected with PG-APS 7 days before harvest. Cultures were
stimulated with 1 0 Mg Con A per well.
When co-cultured with normal control cells, irradiated cells
from PG-APS injected rats were still significantly (P < 0-05)
more suppressive than irradiated control cells. Co-culture of
normal control cells with irradiated control cells did not result in
significant suppression, thus, mixing with irradiated cells is not
suppressive in itself (data not shown).
Mediators ofsuppression
To determine if prostaglandin production and/or oxygen
radicals play a role in the expression of suppressor cell activity,
indomethacin and catalase were added to the cell cultures (Table
2). Either indomethacin or catalase, added singly, partially
reversed suppression of control spleen cell proliferation by cells
from PG-APS injected rats, in response to Con A (P < 0 05). The
combination of indomethacin and catalase was more effective
than either alone. Unlike the removal of adherent cells by nylon
wool or carbonyl iron, the addition of indomethacin and
catalase did not restore the proliferative response to control
levels.
Persistence of suppression
Lewis rats treated with an arthropathic dose of PG-APS
remained suppressed through day 86 post-injection, but had
recovered responsiveness by day 370 (Table 3). On days 7 to 86,
the response to Con A of unfractionated cells from Lewis rats
was 5% or less compared to control cells. Unlike earlier time
points, on day 86 the removal of adherent cells did not increase
the proliferative response of cells from PG-APS injected Lewis
rats. On day 370, the response to Con A stimulation ofcells from
injected animals was not significantly different from that of
control cells.
Development of immunosuppression in rat strains susceptible or
resistant to cell-wall induced arthritis
Spleen cells from susceptible Lewis and Sprague-Dawley strains
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injected with PG-APS were suppressed in their response to Con
A (Table 4). Unfractionated cells from the resistant Buffalo rats
injected with PG-APS proliferated 71% as well as control cells
stimulated with Con A, in contrast to cells from the Lewis rats
which proliferated only 5% as well as control cells, and cells
from Sprague-Dawley rats whose response was only 8% of
control cells. The responses of non-adherent cells from all
strains were in the normal range (Table 4).
DISCUSSION
An arthropathic dose of an aqueous suspension of PG-APS in
rat strains susceptible to cell wall-induced arthritis induced
suppression of spleen cell proliferation in response to T
lymphocyte mitogens. This is not due to a shift in the
concentration of mitogen required for an optimal response, as
shown by the complete lack of response of cells from PG-APS
injected animals to a wide range of mitogen concentrations. A
nylon wool adherent cell mediates this suppression since
removal of these cells restored the proliferative capacity of the
remaining non-adherent cells.
In addition to being adherent the suppressor cell is actively
phagocytic and able to function following treatment with 3,000
rads of radiation. Macrophages are known to be adherent,
phagocytic, and relatively radioresistant (Weinblatt, Vogel &
Rosenstreich, 1981; Sopori et al., 1981; Vetvicka, Fornusek &
Tlaskalova, 1981; LeBlanc & Russel, 1981). Although none of
these properties is specific for macrophages, collectively they
distinguish the macrophage from T suppressor lymphocytes.
We conclude that T lymphocytes are not the effectors of this
immunosuppression, at least over the first 5 weeks; however, by
86 days after PG-APS injection suppression is mediated by a
non-adherent cell which could be a T lymphocyte.
Interfering with prostaglandin synthesis, with indometha-
cin, or interfering with oxygen radical production with catalase
only partially abrogates the suppression, and the effects of these
agents are additive. These results suggest that the suppressor
activity is mediated in part by prostaglandins and oxygen
radicals, but these mechanisms do not account for the major
suppressive effect. This agrees with what is known of the
mechanism of action of suppressor macrophages, which have
been shown to suppress a number of in vitro measures of T
lymphocyte function, including the generation ofcytotoxic cells,
proliferative response to mitogens, and the mixed lymphocyte
response (Sopori et al., 1981; Goodwin, Bankhurst & Massmer,
1977; Metzger, Hoffeld & Oppenheim, 1980). A recent report of
deficient IL-2 production by spleen cells from PG-APS injected
rats describes a mechanism which does not involve prostaglan-
dins or oxygen radicals, and which may be involved in the
suppressor activity described here (Ridge et al., 1986).
The experiments assessing the level of immunosuppression
at various times after PG-APS treatment demonstrate that rats
remain immunosuppressed for at least 86 days following a single
arthropathic dose ofPG-APS, although the nature ofthe lack of
responsiveness is different by day 86 than on previous days. On
days 7 to 34, removal of adherent cells largely restores
proliferative capacity of cells from treated animals, indicating
that the suppression is primarily due to an adherent cell. On day
86 non-adherent cells fail to proliferate, suggesting that either a
non-adherent suppressor cell has become active, or that the day
86 spleens lack responding cells. Recovery of responsiveness to
Con A was noted by day 370.
As recorded in the introduction, immunosuppression is
found in many chronic inflammatory diseases. The data pre-
sented here, showing that rats suffering from an experimentally
induced chronic inflammation are immunosuppressed, are
consistent with these reports. Suppressor macrophages have
also been shown to occur naturally, both in experimental
animals (Raff & Heinrich, 1977) and man (Rice, Laughter &
Twomey, 1979). Experiments with gnotobiotic rats have shown
that these suppressor cells depend on colonization of the host
with normal flora for their induction, as uncolonized host
animals show no naturally occurring suppressor macrophage
activity (Mattingly et al., 1979). The results presented here
suggest that it may be the persistent, poorly biodegradable cell
walls of the normal flora bacteria which induce suppressor
macrophages.
There is no direct evidence as to the importance of the host's
immunosuppressed state, and the role of suppressor macro-
phages, in the pathogenesis of cell wall-induced arthritis. This
paper and other studies (Hunter et al., 1980; Ridge et al., 1986)
have shown that systemic measures of CMI are suppressed in
the arthritic animals; thus severe joint disease can evolve at a
time when some T cell functions are suppressed. One hypothesis
is that suppression of T cells alters processing of bacterial cell
wall debris, contributing to persistence of these toxic, immuno-
genic structures in tissues. However, rnu/rnu athymic rats do
not develop severe chronic joint injury when injected with an
arthropathic dose of PG-APS, although the early joint inflam-
mation is no different than euthymic littermates (Ridge et al.,
1985; Allen et al., 1985). It is possible that suppression ofcertain
T cell functions is important in the establishment of disease,
while activation of other T cell functions is required for
progression of chronic, destructive joint injury.
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